Background Patients with severe bacterial infections often experience delay in receiving
appropriate treatment. Consolidated evidence of the impact of delayed appropriate …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Introduction Bloodstream infections are associated with high mortality rates and contribute
substantially to healthcare costs, but a consensus on the prognostic benefits of appropriate …

Background The global emergence and spread of extended-spectrum beta-lactamase
(ESBL)-producing Enterobacterales, especially Escherichia coli and Klebsiella pneumoniae …

Purpose Hospital-acquired pneumonia (HAP) caused by carbapenem-resistant K.
pneumoniae (CRKP), especially in elderly patients, results in high morbidity and mortality …

Background Managing blood stream infection in Africa is hampered by lack of
bacteriological support needed for antimicrobial stewardship, and background data needed …

Background E. coli is an under-recognized cause of bacterial community-acquired
pneumonia (CAP). The objective of this study was to describe the epidemiology, risk factors …

Klebsiella pneumoniae (K. pneumoniae) is an important pathogen causing various types of
human infections in Taiwan. Carbapenemases have increasingly been reported in …

Abstract Objectives Bloodstream infections (BSIs) caused by extended-spectrum beta-
lactamase-producing Enterobacteriaceae (ESBL-PE) have become a worldwide public …

Background Carbapenems are widely used for the management of bloodstream infections
(BSIs) caused by extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL …